{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-299375","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.605521+00:00","generated_at":"2026-06-21T08:55:59.024446+00:00","sec_items":["1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Amylyx CMO Patrick Yeramian moves to part-time, salary reduced to $214K; successor search ongoing","bullets":["CMO Patrick Yeramian's working hours reduced to 20 per week as of Dec 1, 2022.","Base salary adjusted to $214,000 annually from prior rate (not disclosed).","Company expects Yeramian to transition into retirement; no definitive date set.","Full-time successor search initiated as part of management succession process.","Yeramian's reduced schedule not the result of any disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-299375","json":"https://secwatch.observer/filing/0001193125-22-299375.json","markdown":"https://secwatch.observer/filing/0001193125-22-299375.md","text":"https://secwatch.observer/filing/0001193125-22-299375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000119312522299375/0001193125-22-299375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000119312522299375/d356648d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:55:59.024446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}